Literature DB >> 336544

Suppression of immunity to Mycobacterium lepraemurium infection.

M J Lefford, G B Mackaness.   

Abstract

After injection of 10(8) live Mycobacterium lepraemurium (MLM) into the left hind footpad of mice, there is development of local swelling attributable to a granuloma of the cell-mediated immunity type. Concomitant intravenous inoculation of live MLM delays and may even suppress footpad swelling, the effects being proportional to the intravenous dose of organisms. Concomitant footpad infection and intravenous inoculation of 10(9) dead MLM also delays footpad swelling, but over a period of months the feet become excessively swollen. The excessive swelling is due to local enhancement of infection as evidenced by an increase in the number of MLM per footpad. Attempts were made to prevent such immunosuppression by splenectomy or treatment with BCG. Splenectomy was entirely without effect, but 10(7) live BCG administered intravenously 2 to 4 weeks before dead MLM prevented enhancement of infection. The mediator of the immunosuppressive mechanism that results in enhanced infection remains to be elucidated, but it is unlikely to be antibody or immune complexes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336544      PMCID: PMC421241          DOI: 10.1128/iai.18.2.363-369.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  The effect of splenectomy on the formation of circulating antibody in the adult male albino rat.

Authors:  D A ROWLEY
Journal:  J Immunol       Date:  1950-04       Impact factor: 5.422

2.  Influence of dose and route of antigen injection on the immunological induction of T cells.

Authors:  P H Lagrange; G B Mackaness; T E Miller
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

3.  Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells.

Authors:  T E Miller; G B Mackaness; P H Lagrange
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

Review 4.  Blocking antibodies and enhancement.

Authors:  G H Heppner
Journal:  Ser Haematol       Date:  1972

5.  The walls of Mycobacterium lepraemurium: chemistry and ultrastructure.

Authors:  P Draper
Journal:  J Gen Microbiol       Date:  1971-12

Review 6.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

7.  Experimental murine leprosy: induction of immunity and immune paralysis to Mycobacterium lepraemurium in C57BL mice.

Authors:  O Closs
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

Review 8.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

9.  Development of delayed-type hypersensitivity during Mycobacterium lepraemurium infection in mice.

Authors:  L W Poulter; M J Lefford
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

10.  Feedback inhibition of specifically sensitized lymphocytes.

Authors:  G B Mackaness; P H Lagrange; T E Miller; T Ishibashi
Journal:  J Exp Med       Date:  1974-03-01       Impact factor: 14.307

View more
  10 in total

1.  Induction of immunity against live Mycobacterium lepraemurium: a requirement for viable bacilli?

Authors:  M Løvik; O Closs
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

2.  Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis.

Authors:  Alexandre Paulo Machado; Maria Regina Regis Silva; Olga Fischman
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

3.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.

Authors:  T J Holzer; K E Nelson; R G Crispen; B R Andersen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

4.  Mycobacterium lepraemurium infection of nude athymic (nu/nu) mice.

Authors:  M J Lefford
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

5.  Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

6.  Enhancement of resistance in Mycobacterium lepraemurium infected C3H mice by treatment with sonicated M. lepraemurium or splenectomy.

Authors:  R Turcotte; J Chaput; S Lemieux
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

7.  Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice.

Authors:  P H Lagrange; B Hurtrel
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

8.  Induction and suppression of cross-reactive antituberculosis immunity after Mycobacterium lepraemurium infection of mice.

Authors:  M J Lefford; P S Logie
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Cutaneous unresponsiveness to Mycobacterium bovis BCG in intravenously infected mice.

Authors:  R Turcotte; A Forget
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

10.  Effect of Mycobacterium bovis BCG vaccination upon Mycobacterium lepraemurium infection.

Authors:  M J Lefford; R Morgan; P S Logie
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.